IL32020A - Antacid compositions - Google Patents

Antacid compositions

Info

Publication number
IL32020A
IL32020A IL32020A IL3202069A IL32020A IL 32020 A IL32020 A IL 32020A IL 32020 A IL32020 A IL 32020A IL 3202069 A IL3202069 A IL 3202069A IL 32020 A IL32020 A IL 32020A
Authority
IL
Israel
Prior art keywords
antacid
composition
gelation
magnesium
viscosity
Prior art date
Application number
IL32020A
Other languages
English (en)
Other versions
IL32020A0 (en
Original Assignee
Brown G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brown G filed Critical Brown G
Publication of IL32020A0 publication Critical patent/IL32020A0/xx
Publication of IL32020A publication Critical patent/IL32020A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL32020A 1968-04-18 1969-04-14 Antacid compositions IL32020A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72217668A 1968-04-18 1968-04-18
US78572768A 1968-12-20 1968-12-20

Publications (2)

Publication Number Publication Date
IL32020A0 IL32020A0 (en) 1969-06-25
IL32020A true IL32020A (en) 1972-11-28

Family

ID=27110553

Family Applications (1)

Application Number Title Priority Date Filing Date
IL32020A IL32020A (en) 1968-04-18 1969-04-14 Antacid compositions

Country Status (15)

Country Link
JP (1) JPS4621672B1 (fr)
AU (1) AU438147B2 (fr)
BE (1) BE731695A (fr)
CA (1) CA959760A (fr)
CH (1) CH536114A (fr)
DE (1) DE1919802A1 (fr)
DK (1) DK127269B (fr)
ES (1) ES366173A1 (fr)
FI (1) FI50831C (fr)
FR (1) FR2007475A1 (fr)
GB (1) GB1269987A (fr)
IL (1) IL32020A (fr)
NL (1) NL6906087A (fr)
NO (1) NO129077B (fr)
SE (1) SE388356B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1401257A (en) * 1972-06-30 1975-07-16 Miles Lab Process for preparing a spray dried calcium carbonate composition
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
SE7905972L (sv) * 1979-07-09 1981-01-10 Haessle Ab Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand
SG72632A1 (en) * 1985-04-18 2000-05-23 Procter & Gamble Treatment of non-ulcer dyspepsia with bismuth salts
IT1215332B (it) * 1987-01-12 1990-02-08 Crinos Industria Farmaco Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
DE3812378A1 (de) * 1988-04-14 1989-10-26 Theo Mertens Mobile erntegutmahl- und -mischvorrichtung
US4988679A (en) * 1989-01-03 1991-01-29 Leonard Chavkin Liquid sustained release composition
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
DE4305919A1 (de) * 1993-02-26 1994-09-01 Ruediger Potthoff Transportsilo für Kunststoff-Granulat
WO2003066022A2 (fr) * 2002-02-04 2003-08-14 Pharmacia Corporation Preparation pharmaceutique stable pour le traitement des troubles gastro-intestinaux
AU2003211627A1 (en) * 2002-03-04 2003-09-16 Medrx Co., Ltd. Liquid matrix undergoing phase transfer in vivo and liquid oral preparations
US20030232092A1 (en) * 2002-06-14 2003-12-18 Hasenmayer Donald L. Liquid antacid compositions
AU2015253187B2 (en) 2014-04-29 2017-10-05 The Procter & Gamble Company Method for making bismuth-containing liquid pharmaceutical suspensions
US9486460B2 (en) 2014-04-29 2016-11-08 The Procter & Gamble Company Bismuth containing liquid pharmaceutical suspensions
CN114732828A (zh) * 2022-04-27 2022-07-12 广西南宁百会药业集团有限公司 一种铝碳酸镁混悬液及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621147A (fr) *

Also Published As

Publication number Publication date
SE388356B (sv) 1976-10-04
AU438147B2 (en) 1973-07-18
ES366173A1 (es) 1971-04-01
DK127269B (da) 1973-10-15
CA959760A (en) 1974-12-24
IL32020A0 (en) 1969-06-25
BE731695A (fr) 1969-10-20
NL6906087A (fr) 1969-10-21
GB1269987A (en) 1972-04-12
FR2007475A1 (fr) 1970-01-09
JPS4621672B1 (fr) 1971-06-19
FI50831B (fr) 1976-04-30
NO129077B (fr) 1974-02-25
FI50831C (fi) 1976-08-10
DE1919802A1 (de) 1969-11-06
CH536114A (fr) 1973-04-30
AU5353969A (en) 1970-10-22

Similar Documents

Publication Publication Date Title
US3579634A (en) Novel antacid compositions and methods for their administration
IL32020A (en) Antacid compositions
US3843778A (en) Antacids
US3974272A (en) Palatable cholestyramine coacervate compositions
US4167558A (en) Novel sustained release tablet formulations
US4140755A (en) Sustained release tablet formulations
US5667802A (en) Antacid composition
JPH0535130B2 (fr)
CA1259919A (fr) Compose antiacide rehydratable
IE61062B1 (en) Pharmaceutical composition containing ibuprofen and aluminium hydroxide
US4115553A (en) Antacid tablets
US4869902A (en) Antacid composition
US4705683A (en) Pharmaceutical compositions
US3272704A (en) Stable aluminum hydroxide-magnesium compound codried gel antacids and process of making the same
US4704278A (en) Fluidized magaldrate suspension
AU578690B2 (en) Antacid composition
GB2384986A (en) Solid compositions for the treatment of disorders of the upper gastrointestinal tract
JP2735559B2 (ja) 懸濁液
GB1582737A (en) Concentrated magnesium hydroxide suspensions or emulsions and method for production thereof
US3326755A (en) Alginate containing antacid compositions
NZ194165A (en) Antacidaqueous suspension containing aluminium hydroxide
US3215601A (en) Antacid composition and method of making same
US4652446A (en) Pharmaceutical compositions
US3245876A (en) Antacid compositions containing high concentrations of magnesium hydroxide and process of making the same
US3208906A (en) Glycine-stabilized aluminum hydroxidemagnesium compound codried gel antacids and process of making the same